2. Announcement of voting results

The President read out the results of the votes on:

The EU’s Cybersecurity Strategy for the Digital Decade
Motion for a resolution B9-0305/2021

(Simple majority needed)

AMENDMENT

See Texts adopted (P9_TA(2021)0286)
(‘Results of votes’ annex, item 23)

European Parliament’s scrutiny on the ongoing assessment by the Commission and the Council of the national recovery and resilience plans
Joint motion for a resolution RC-B9-0331/2021

(Simple majority needed)

AMENDMENTS

See Texts adopted (P9_TA(2021)0288)
(‘Results of votes’ annex, item 25)

Regulations and general conditions governing the performance of the Ombudsman’s duties
Report on a draft regulation of the European Parliament laying down the regulations and general conditions governing the performance of the Ombudsman’s duties (Statute of the European Ombudsman) and repealing Decision 94/262/ECSC, EC, Euratom [2021/2053(INL)] - Committee on Constitutional Affairs. Rapporteur: Paulo Rangel (A9-0174/2021)

(Simple majority needed)

ANNEX (DRAFT PARLIAMENT REGULATION)

Adopted by single vote (P9_TA(2021)0280)

(‘Results of votes’ annex, item 17)

REQUEST TO POSTPONE THE FINAL VOTE

The request to postpone was adopted by RCV (658 in favour, 12 against, 22 abstentions).

Transitional provisions in order to address the impact of the COVID-19 crisis (amendment of Regulation (EU) 2016/1628) ***I
[COM(2021)0254 - C9-0185/2021 - 2021/0129(COD)]

(Simple majority needed)

COMMISSION PROPOSAL

Adopted (P9_TA(2021)0281)
(‘Results of votes’ annex, item 18)

Parliament’s first reading thus closed.

The conflict of interest of the Prime Minister of the Czech Republic
Motion for a resolution B9-0303/2021

(Simple majority needed)

MOTION FOR A RESOLUTION

Adopted (P9_TA(2021)0282)
(‘Results of votes’ annex, item 19)

Meeting the Global COVID-19 challenge: effects of waiver of the WTO TRIPS agreement on COVID-19 vaccines, treatment, equipment and increasing production and manufacturing capacity in developing countries
Joint motion for a resolution RC-B9-0306/2021

(Simple majority needed)

JOINT MOTION FOR A RESOLUTION

Adopted (P9_TA(2021)0283)
(‘Results of votes’ annex, item 20)

(Motions for resolutions B9-0308/2021 and B9-0310/2021 fell.)

Objection pursuant to Rule 112(2) and (3): Maximum residue limit for imidacloprid
Motion for a resolution B9-0313/2021

(Simple majority needed)

MOTION FOR A RESOLUTION

Adopted (P9_TA(2021)0284)
(‘Results of votes’ annex, item 21)

Objection pursuant to Rule 112(2) and (3): Active substances, including flumioxazine
Motion for a resolution B9-0312/2021

(Simple majority needed)

MOTION FOR A RESOLUTION

Adopted (P9_TA(2021)0285)
(‘Results of votes’ annex, item 22)